Pharma major Novartis on Saturday announced that its drug Lutathera has shown significantly improved patient outcomes for gastroenteropancreatic neuroendocrine tumors....
III
Exclusive
Breaking News
Commentary: Psychological distress among healthcare students in Poland from COVID-19 to war on Ukraine: a cross-sectional exploratory study
Knowledge, attitude, and practice of healthcare professionals towards irritable bowel syndrome: a multicenter, cross-sectional study
Bernard Healthcare is to enhance Japanese-standard gastrointestinal endoscopy
Mental Health Tools for Kids
Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study | BMC Gastroenterology